- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 576.31M sh |
| Stock Issued | Q1 2025 · Mar 31, 2025 | 87K sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $9M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.18M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.03M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.2M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.03M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $16.49M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.34M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $25.22M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $14.22M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 86.02K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $13.58K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.09M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $11.67M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $13.11M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$21.15 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$21.15 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $173.9K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.74M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.81M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $1.77M |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.61M |